Industry News

Immunizations Save Lives - WHO Urges Parents to Continue to Vaccinate Their Children

Immunizations Save Lives - WHO Urges Parents to Continue to Vaccinate Their Children

BEIJING, AUGUST 3, 2018 - The World Health Organization urges Chinese citizens to continue to use quality-assured vaccines to prevent diseases in China. Immunization is one of the most effective, and cost-effective public health interventions in the world for preventing illness and death.

The proof is in the numbers. Serious disease rates tied to meningitis, which affected more than 3 million people in China in 1967, have fallen by 99 per cent since that time.

Immunization has also dramatically reduced other vaccine-preventable diseases in China, including meningococcal meningitis and hepatitis B among children. Between 1992 and 2014, an estimated 120 million hepatitis B virus infections and 28 million chronic infections were averted by the use of hepatitis B vaccine. Thanks to immunization, today’s generation of Chinese children are virtually hepatitis B free – meaning their risk of developing nasty diseases such as cirrhosis of the liver and liver cancer in the future are drastically reduced.

Hualan | Hualan Biological

In short, over the last four decades, China’s Expanded Program on Immunization has fundamentally altered the course of the nation’s public health.

Globally, immunization currently prevents between 2-3 million deaths every year. Even more deaths, an additional 1.5 million could be avoided, if global immunization coverage is improved.

Without widespread immunization, diseases that have largely disappeared in China run the risk of returning, jeopardizing public health and safety once again. WHO urges parents to continue to vaccinate their children. The continued success of the immunization program – and the health and well-being of this, and future generations of Chinese children – depends on it.

 

http://www.wpro.who.int/china/mediacentre/releases/2018/20180803-Immunizations-Save-Lives/en/


TAG:  Vaccine, Hualan Bio, Group ACYW135 Meningococcal Polysaccharide Vaccine, Hepatitis B Vaccine